个人中心 - 老虎社区

kenlim45

IP属地：未知

帖子 · 100帖子 · 100
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- kenlim45kenlim45
  ·2021-12-02
  Oh.
  非常抱歉，此主贴已删除
  1,618 评论
  点赞
  分享
  举报
- kenlim45kenlim45
  ·2021-12-01
  Like
  非常抱歉，此主贴已删除
  1,225 评论
  2
  分享
  举报
- kenlim45kenlim45
  ·2021-12-01
  Ok
  非常抱歉，此主贴已删除
  1,241 评论
  4
  分享
  举报
- kenlim45kenlim45
  ·2021-12-01
  Ok
  非常抱歉，此主贴已删除
  1,198 评论
  1
  分享
  举报
- kenlim45kenlim45
  ·2021-12-01
  Good
  5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market
  Here are the stocks to watch as the omicron variant gives rise to a new vaccine race
  5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market
  1,393 评论
  2
  分享
  举报
- kenlim45kenlim45
  ·2021-12-01
  Ok
  Gold and silver stocks jumped in morning trading
  Gold and silver stocks jumped in morning trading.
  Gold and silver stocks jumped in morning trading
  1,595 评论
  2
  分享
  举报
- kenlim45kenlim45
  ·2021-11-19
  Like
  非常抱歉，此主贴已删除
  1,148 评论
  1
  分享
  举报
- kenlim45kenlim45
  ·2021-11-19
  Like
  非常抱歉，此主贴已删除
  1,147 评论
  点赞
  分享
  举报
- kenlim45kenlim45
  ·2021-11-19
  Great
  Apple Stock Surges On Report Saying Autonomous Car Coming in 2025
  Apple is accelerating its electric car project under Kevin Lynch Bloomberg News reported Thursday, w
  Apple Stock Surges On Report Saying Autonomous Car Coming in 2025
  1,466 评论
  1
  分享
  举报
- kenlim45kenlim45
  ·2021-11-19
  Great 👍
  Electric Vehicle Checkpoint: EV Market May Quadruple By 2030
  The current EV market is expected to rise to $957.42 billion from $208.95 billion, a number that cou
  Electric Vehicle Checkpoint: EV Market May Quadruple By 2030
  1,519 评论
  2
  分享
  举报
暂无粉丝

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4087993342728370","uuid":"4087993342728370","gmtCreate":1624890280241,"gmtModify":1625141991387,"name":"kenlim45","pinyin":"kenlim45","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/041f7cb113fb34ffb16e6418486502fe","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":10,"headSize":67,"tweetSize":100,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":603288819,"gmtCreate":1638413607025,"gmtModify":1638414419862,"author":{"id":"4087993342728370","authorId":"4087993342728370","name":"kenlim45","avatar":"https://static.tigerbbs.com/041f7cb113fb34ffb16e6418486502fe","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087993342728370","authorIdStr":"4087993342728370"},"themes":[],"htmlText":"Oh.","listText":"Oh.","text":"Oh.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603288819","repostId":"1185859700","repostType":2,"isVote":1,"tweetType":1,"viewCount":1618,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609535318,"gmtCreate":1638295435961,"gmtModify":1638295436077,"author":{"id":"4087993342728370","authorId":"4087993342728370","name":"kenlim45","avatar":"https://static.tigerbbs.com/041f7cb113fb34ffb16e6418486502fe","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087993342728370","authorIdStr":"4087993342728370"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609535318","repostId":"1120422018","repostType":4,"isVote":1,"tweetType":1,"viewCount":1225,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609535064,"gmtCreate":1638295400364,"gmtModify":1638295400445,"author":{"id":"4087993342728370","authorId":"4087993342728370","name":"kenlim45","avatar":"https://static.tigerbbs.com/041f7cb113fb34ffb16e6418486502fe","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087993342728370","authorIdStr":"4087993342728370"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609535064","repostId":"2187817235","repostType":4,"isVote":1,"tweetType":1,"viewCount":1241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609532523,"gmtCreate":1638295358253,"gmtModify":1638295358334,"author":{"id":"4087993342728370","authorId":"4087993342728370","name":"kenlim45","avatar":"https://static.tigerbbs.com/041f7cb113fb34ffb16e6418486502fe","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087993342728370","authorIdStr":"4087993342728370"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609532523","repostId":"1179486032","repostType":4,"isVote":1,"tweetType":1,"viewCount":1198,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609532135,"gmtCreate":1638295332440,"gmtModify":1638295332519,"author":{"id":"4087993342728370","authorId":"4087993342728370","name":"kenlim45","avatar":"https://static.tigerbbs.com/041f7cb113fb34ffb16e6418486502fe","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087993342728370","authorIdStr":"4087993342728370"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609532135","repostId":"1190156196","repostType":4,"repost":{"id":"1190156196","kind":"news","pubTimestamp":1638242388,"share":"https://www.laohunote.com/m/news/1190156196?lang=&edition=full","pubTime":"2021-11-30 11:19","market":"us","language":"en","title":"5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1190156196","media":"InvestorPlace","summary":"Here are the stocks to watch as the omicron variant gives rise to a new vaccine race","content":"<p>Here are the stocks to watch as the omicron variant gives rise to a new vaccine race</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/537aabc5fd6c7ca4f614ce1b37dc0a75\" tg-width=\"1024\" tg-height=\"576\" width=\"100%\" height=\"auto\"><span>Source: Shutterstock</span></p>\n<p>As Black Friday approached, most investors were speculating on what the supply chain crisis would mean for the year’s biggest shopping holiday. By the time shopping began, though, most minds were on another news story. A new Covid-19 variant had been detected in South Africa and it was quickly spreading to Europe. Labeled the omicron variant, this new Covid-19 strain poses a threat to the pandemic recovery story. Perhaps most importantly, we don’t yet know how big that threat is. Scientists haveindicatedthat it will take at least a few weeks for them to assess the effectiveness of vaccines against the new variant, which features multiple mutations. As investors ponder what this means for markets, focus has shifted to one specific question: What does this mean for vaccine stocks?</p>\n<p>Investors have expressed concern at what the the emergence of a new variant may mean for markets. It bears noting, though, that such a scenario creates a new opportunity for vaccine stocks, specifically for a new company to pull into the lead.</p>\n<p>While&nbsp;<b>Pfizer’s</b>(NYSE:<b><u>PFE</u></b>)&nbsp;success in&nbsp;producing&nbsp;a vaccine approved for children has helped it maintain a lead over its competitors, other companies recognize the need for further innovation within the vaccine space. Scientists and researchers have yet to reach a conclusion as to how the new variant will react to current vaccines, but the companies producing them are already working around the clock.</p>\n<p>Many vaccine stocks were trending this morning as the omicron variant dominated news coverage. Let’s take a look at what the most prominent vaccine producers are saying and when we can expect to see progress.</p>\n<ul>\n <li><b>Moderna</b>(NASDAQ:<b><u>MRNA</u></b>)</li>\n <li><b>Pfizer</b>(NYSE:<b><u>PFE</u></b>)</li>\n <li><b>BioNTech</b>&nbsp;(NASDAQ:<b><u>BNTX</u></b>)</li>\n <li><b>Johnson &amp; Johnson</b>(NYSE:<b><u>JNJ</u></b>)</li>\n <li><b>Novavax</b>(NASDAQ:<b><u>NVAX</u></b>)</li>\n</ul>\n<p><b>Moderna (MRNA)</b></p>\n<p>Moderna was one of the first companies to have its executive team discuss address the omicron variant.</p>\n<p>On Sunday, CMO Paul Burton spoke to<i>BBC’s</i>Andrew Marr and said Moderna was hoping to see clinical trials of an omicron-specific booster begin within60 to 90 days. CEO Stephane Bancel recentlyspoketo<i>CNBC’s</i>“Squawk Box” on the topic of an omicron- targeting vaccine. While he stated that it will likely take months for the company to develop, produce and ship a vaccine with the ability to target that specific variant, he noted that a booster shot containing a higher 100-microgram dose could be made available much sooner.</p>\n<p>Bancel also floated the possibility of administering higher doses of the current vaccines to particularly high-risk patients, such as those in the elderly or immunocompromised categories.</p>\n<p>This talk of an effective booster that could take on the new variant has sent MRNA stock shooting up today. As of this writing, vaccine stocks are having a good day and Moderna has risen by more than 10%. Today’s gains have put it up by more than 30% for the past five days.</p>\n<p>While&nbsp;the head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.</p>\n<p>\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times&nbsp;in an interview.</p>\n<p>\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"</p>\n<p><b>Pfizer (PFE)</b></p>\n<p>No pharmaceutical company has received as much positive press for its vaccine innovations as Pfizer. Earlier this month, CEO Albert Bourla wasrecommended by one&nbsp;<i>InvestorPlace</i>&nbsp;contributorfor CEO of the year.</p>\n<p>The industry leader alsodiscussedthe new variant earlier today, stating that he believed that Pfizer’s Covid-19 pill would prove effective against it. He noted that the treatment method was designed with the thought process that most virus mutations were coming in spikes, exactly what we are seeing so far from the omicron variant. This gives him, he said, a “very high level of confidence” that the oral treatment, Paxlovid, will prove well-suited to help patients with the new Covid-19 strain.</p>\n<p>Clinical trials have found that when Paxlovid is taken with HIV drug ritonavir, it reduces hospitalization and death by 89% if taken within three days after symptoms have begun.</p>\n<p>While Bourla is still not able to offer much on the effectiveness of the company’s two-dose vaccine against the new variant, he experts it to offer at least some protection. He also said that Pfizer is already at work on a new vaccine and that it produced a DNA template on Friday, speculating that it could be ready within 100 days.</p>\n<p>It is worth noting that Pfizer has been able to create vaccines for previous variants in that timeframe but did not end up having to administer them, as the previously distributed vaccines remained effective.</p>\n<p><b>BioNTech (BNTX)</b></p>\n<p>Pfizer’s original vaccine partner isn’t missing a beat, either.</p>\n<p>The German biotech innovatortold<i>Business Insider</i>that it is already at work on the development of an adapted vaccine to combat the omicron variant. According to the company’s spokespeople, the first steps of such a process “overlap with the research necessary” to evaluate the necessity of a new shot. This approach should enable its research team to move forward as quickly as possible.</p>\n<p>Like its competitors, BioNTech expects to acquire the data necessary to determine next steps in roughly two weeks, as medical researchers rush to examine new cases. In an attempt to keep the process as efficient as possible, the company is already testing its existing vaccine doses. Like Pfizer, it claims that it will be able to ship out this adapted vaccine within 100 days should it prove necessary.</p>\n<p>Like other vaccine stocks, BNTX is having a good day as speculation regarding the vaccine mounts. Shares are up almost 4% as of this writing. Not unlike its competitor Moderna, BioNTech is up almost 20% for the week after seeing a period of mostly flatlining. Earlier this Summer,<i>InvestorPlace</i>&nbsp;analyst Louis Navelliercalledit a better buy among vaccine stocks than Pfizer.</p>\n<p><b>Johnson &amp; Johnson (JNJ)</b></p>\n<p>Like its competitors, Johnson &amp; Johnson is already at work on ways to combat the new variant. Still waiting on further data, though, the company hasstatedit “will progress [its new vaccine] into clinical studies if needed.”</p>\n<p>Mathai Mammen, global head of research and development at J&amp;J subsidiary Janssen Pharmaceuticals, says that the company remains confident in the “robust humoral and cell-mediated responses” that its original vaccine has elicited in patients to date, giving the company confidence in its ability to adapt its current vaccine to handle the omicron variant.</p>\n<p>Mammen added that the company has already begun work on a new vaccine for exactly that purpose and will “rapidly progress into clinical trails” if it is deemed necessary. It has beenreportedthat testing has already begun.</p>\n<p><b>Novavax (NVAX)</b></p>\n<p>A later player to the vaccine race, Novavax hasn’t had the same success in the U.S. as Pfizer or Moderna.</p>\n<p>However, the company recognizes it has a chance to make up the lost ground. In fact, it is already working to develop a vaccine to combat the omicron variant. Novavax hasstatedthat its vaccine will contain the mutated spikes that have experts worried about the variant, thereby enabling recipients to develop necessary immune responses. Its spokespeople have also stated that the testing and developing of the new vaccine will likely take “a few weeks.”</p>\n<p>While Novavax has not filed for approval for its initial Covid-19 in the U.S. yet, it received the green light from regulators in both Indonesia and the Philippines.</p>\n<p>As&nbsp;<i>InvestorPlace</i>&nbsp;Assistant News Writer&nbsp;Eddie Pan&nbsp;reported&nbsp;this morning, NVAX is a name to watch among vaccine stocks as speculation mounts. While no one is likely to know too much for at least two weeks, companies aren’t wasting any time in building on their vaccine innovations in attempt to pull ahead in the vaccine race. Novavax may not have garnered U.S. authorization yet, but it has risen to prominence by way of its global vaccine distribution work, an edge that earned it ahigh rankingamong second-shot vaccine stocks to buy.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 11:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Here are the stocks to watch as the omicron variant gives rise to a new vaccine race\nSource: Shutterstock\nAs Black Friday approached, most investors were speculating on what the supply chain crisis ...</p>\n\n<a href=\"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞"},"source_url":"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190156196","content_text":"Here are the stocks to watch as the omicron variant gives rise to a new vaccine race\nSource: Shutterstock\nAs Black Friday approached, most investors were speculating on what the supply chain crisis would mean for the year’s biggest shopping holiday. By the time shopping began, though, most minds were on another news story. A new Covid-19 variant had been detected in South Africa and it was quickly spreading to Europe. Labeled the omicron variant, this new Covid-19 strain poses a threat to the pandemic recovery story. Perhaps most importantly, we don’t yet know how big that threat is. Scientists haveindicatedthat it will take at least a few weeks for them to assess the effectiveness of vaccines against the new variant, which features multiple mutations. As investors ponder what this means for markets, focus has shifted to one specific question: What does this mean for vaccine stocks?\nInvestors have expressed concern at what the the emergence of a new variant may mean for markets. It bears noting, though, that such a scenario creates a new opportunity for vaccine stocks, specifically for a new company to pull into the lead.\nWhile Pfizer’s(NYSE:PFE) success in producing a vaccine approved for children has helped it maintain a lead over its competitors, other companies recognize the need for further innovation within the vaccine space. Scientists and researchers have yet to reach a conclusion as to how the new variant will react to current vaccines, but the companies producing them are already working around the clock.\nMany vaccine stocks were trending this morning as the omicron variant dominated news coverage. Let’s take a look at what the most prominent vaccine producers are saying and when we can expect to see progress.\n\nModerna(NASDAQ:MRNA)\nPfizer(NYSE:PFE)\nBioNTech (NASDAQ:BNTX)\nJohnson & Johnson(NYSE:JNJ)\nNovavax(NASDAQ:NVAX)\n\nModerna (MRNA)\nModerna was one of the first companies to have its executive team discuss address the omicron variant.\nOn Sunday, CMO Paul Burton spoke toBBC’sAndrew Marr and said Moderna was hoping to see clinical trials of an omicron-specific booster begin within60 to 90 days. CEO Stephane Bancel recentlyspoketoCNBC’s“Squawk Box” on the topic of an omicron- targeting vaccine. While he stated that it will likely take months for the company to develop, produce and ship a vaccine with the ability to target that specific variant, he noted that a booster shot containing a higher 100-microgram dose could be made available much sooner.\nBancel also floated the possibility of administering higher doses of the current vaccines to particularly high-risk patients, such as those in the elderly or immunocompromised categories.\nThis talk of an effective booster that could take on the new variant has sent MRNA stock shooting up today. As of this writing, vaccine stocks are having a good day and Moderna has risen by more than 10%. Today’s gains have put it up by more than 30% for the past five days.\nWhile the head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.\n\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times in an interview.\n\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"\nPfizer (PFE)\nNo pharmaceutical company has received as much positive press for its vaccine innovations as Pfizer. Earlier this month, CEO Albert Bourla wasrecommended by one InvestorPlace contributorfor CEO of the year.\nThe industry leader alsodiscussedthe new variant earlier today, stating that he believed that Pfizer’s Covid-19 pill would prove effective against it. He noted that the treatment method was designed with the thought process that most virus mutations were coming in spikes, exactly what we are seeing so far from the omicron variant. This gives him, he said, a “very high level of confidence” that the oral treatment, Paxlovid, will prove well-suited to help patients with the new Covid-19 strain.\nClinical trials have found that when Paxlovid is taken with HIV drug ritonavir, it reduces hospitalization and death by 89% if taken within three days after symptoms have begun.\nWhile Bourla is still not able to offer much on the effectiveness of the company’s two-dose vaccine against the new variant, he experts it to offer at least some protection. He also said that Pfizer is already at work on a new vaccine and that it produced a DNA template on Friday, speculating that it could be ready within 100 days.\nIt is worth noting that Pfizer has been able to create vaccines for previous variants in that timeframe but did not end up having to administer them, as the previously distributed vaccines remained effective.\nBioNTech (BNTX)\nPfizer’s original vaccine partner isn’t missing a beat, either.\nThe German biotech innovatortoldBusiness Insiderthat it is already at work on the development of an adapted vaccine to combat the omicron variant. According to the company’s spokespeople, the first steps of such a process “overlap with the research necessary” to evaluate the necessity of a new shot. This approach should enable its research team to move forward as quickly as possible.\nLike its competitors, BioNTech expects to acquire the data necessary to determine next steps in roughly two weeks, as medical researchers rush to examine new cases. In an attempt to keep the process as efficient as possible, the company is already testing its existing vaccine doses. Like Pfizer, it claims that it will be able to ship out this adapted vaccine within 100 days should it prove necessary.\nLike other vaccine stocks, BNTX is having a good day as speculation regarding the vaccine mounts. Shares are up almost 4% as of this writing. Not unlike its competitor Moderna, BioNTech is up almost 20% for the week after seeing a period of mostly flatlining. Earlier this Summer,InvestorPlace analyst Louis Navelliercalledit a better buy among vaccine stocks than Pfizer.\nJohnson & Johnson (JNJ)\nLike its competitors, Johnson & Johnson is already at work on ways to combat the new variant. Still waiting on further data, though, the company hasstatedit “will progress [its new vaccine] into clinical studies if needed.”\nMathai Mammen, global head of research and development at J&J subsidiary Janssen Pharmaceuticals, says that the company remains confident in the “robust humoral and cell-mediated responses” that its original vaccine has elicited in patients to date, giving the company confidence in its ability to adapt its current vaccine to handle the omicron variant.\nMammen added that the company has already begun work on a new vaccine for exactly that purpose and will “rapidly progress into clinical trails” if it is deemed necessary. It has beenreportedthat testing has already begun.\nNovavax (NVAX)\nA later player to the vaccine race, Novavax hasn’t had the same success in the U.S. as Pfizer or Moderna.\nHowever, the company recognizes it has a chance to make up the lost ground. In fact, it is already working to develop a vaccine to combat the omicron variant. Novavax hasstatedthat its vaccine will contain the mutated spikes that have experts worried about the variant, thereby enabling recipients to develop necessary immune responses. Its spokespeople have also stated that the testing and developing of the new vaccine will likely take “a few weeks.”\nWhile Novavax has not filed for approval for its initial Covid-19 in the U.S. yet, it received the green light from regulators in both Indonesia and the Philippines.\nAs InvestorPlace Assistant News Writer Eddie Pan reported this morning, NVAX is a name to watch among vaccine stocks as speculation mounts. While no one is likely to know too much for at least two weeks, companies aren’t wasting any time in building on their vaccine innovations in attempt to pull ahead in the vaccine race. Novavax may not have garnered U.S. authorization yet, but it has risen to prominence by way of its global vaccine distribution work, an edge that earned it ahigh rankingamong second-shot vaccine stocks to buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1393,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609536750,"gmtCreate":1638295292685,"gmtModify":1638295292800,"author":{"id":"4087993342728370","authorId":"4087993342728370","name":"kenlim45","avatar":"https://static.tigerbbs.com/041f7cb113fb34ffb16e6418486502fe","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087993342728370","authorIdStr":"4087993342728370"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609536750","repostId":"1129131439","repostType":4,"repost":{"id":"1129131439","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638285839,"share":"https://www.laohunote.com/m/news/1129131439?lang=&edition=full","pubTime":"2021-11-30 23:23","market":"us","language":"en","title":"Gold and silver stocks  jumped in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1129131439","media":"Tiger Newspress","summary":"Gold and silver stocks jumped in morning trading.","content":"<p>Gold and silver stocks jumped in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/02c176526990e689ddfc9f7ffa90e282\" tg-width=\"396\" tg-height=\"657\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/fd1aad69af976f6877e0d77ba4618b6e\" tg-width=\"399\" tg-height=\"301\" referrerpolicy=\"no-referrer\"></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gold and silver stocks  jumped in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGold and silver stocks  jumped in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-30 23:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Gold and silver stocks jumped in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/02c176526990e689ddfc9f7ffa90e282\" tg-width=\"396\" tg-height=\"657\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/fd1aad69af976f6877e0d77ba4618b6e\" tg-width=\"399\" tg-height=\"301\" referrerpolicy=\"no-referrer\"></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129131439","content_text":"Gold and silver stocks jumped in morning trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1595,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876631834,"gmtCreate":1637300958398,"gmtModify":1637300958480,"author":{"id":"4087993342728370","authorId":"4087993342728370","name":"kenlim45","avatar":"https://static.tigerbbs.com/041f7cb113fb34ffb16e6418486502fe","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087993342728370","authorIdStr":"4087993342728370"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876631834","repostId":"2184999418","repostType":2,"isVote":1,"tweetType":1,"viewCount":1148,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876633258,"gmtCreate":1637300838495,"gmtModify":1637300838572,"author":{"id":"4087993342728370","authorId":"4087993342728370","name":"kenlim45","avatar":"https://static.tigerbbs.com/041f7cb113fb34ffb16e6418486502fe","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087993342728370","authorIdStr":"4087993342728370"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876633258","repostId":"2184892793","repostType":2,"isVote":1,"tweetType":1,"viewCount":1147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876639412,"gmtCreate":1637300763537,"gmtModify":1637300831140,"author":{"id":"4087993342728370","authorId":"4087993342728370","name":"kenlim45","avatar":"https://static.tigerbbs.com/041f7cb113fb34ffb16e6418486502fe","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087993342728370","authorIdStr":"4087993342728370"},"themes":[],"htmlText":"Great&nbsp;","listText":"Great&nbsp;","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876639412","repostId":"1104598780","repostType":2,"repost":{"id":"1104598780","kind":"news","pubTimestamp":1637279362,"share":"https://www.laohunote.com/m/news/1104598780?lang=&edition=full","pubTime":"2021-11-19 07:49","market":"us","language":"en","title":"Apple Stock Surges On Report Saying Autonomous Car Coming in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1104598780","media":"The Street","summary":"Apple is accelerating its electric car project under Kevin Lynch Bloomberg News reported Thursday, w","content":"<p><a href=\"https://laohu8.com/S/AAPL\">Apple</a> is accelerating its electric car project under Kevin Lynch Bloomberg News reported Thursday, with plans to unveil an autonomous vehicle as early as 2025.</p>\n<p>Apple&nbsp;shares surged to a fresh record high Thursday amid reports that the world's biggest tech company is accelerating its plans to build a self-driving car, and could unveil its debut model as early as 2025.</p>\n<p>Bloomberg News reported that the tech giant is aiming for a fully autonomous vehicle, with new division head Kevin Lynch looking for a faster-than-forecast release.</p>\n<p>The report follows speculation that Apple, which has long been connected to an autonomous driving project, had visited automakers and suppliers in Asia, including $Toyota Motor Co.&nbsp;(<b>TM</b>)$, as part of its early-stage preparations.</p>\n<p>Citigroup analyst Jim Suva&nbsp;argued in March that an electric car rollout could propel Apple to a $3 trillion market cap, while&nbsp;Wedbush analysts Dan Ives, a long-time Apple bull, told&nbsp;<i>TheStreet</i>&nbsp;in August that a so-called Apple Car is \"not a matter of if, it’s a matter of when.\"</p>\n<p>\"I believe they are continuing to build a vision, the infrastructure, they are looking for partnerships on the battery side,\" he said \"They are not going to miss out on the $5 trillion green tidal wave.”</p>\n<p>Apple shares ended 2.85% higher on the session at $157.87 each, an all-time closing high that extends their year-to-date gain to around 22%.</p>\n<p><img src=\"https://static.tigerbbs.com/9379d3e8361da8d07509edd96eb1cf92\" tg-width=\"885\" tg-height=\"630\" width=\"100%\" height=\"auto\"></p>\n<p>Lynch, Apple's vice president of technology, was tabbed to lead Project Titan, the group's&nbsp;autonomous car project, in early summer. That was in addition to the hiring of BWM's Ulrich Kranz, a 30-year industry veteran who lead the German automaker's development of the&nbsp;i3 and i8 electric and hybrid cars.</p>\n<p>Apple posted profits of&nbsp;$1.24 per share for its fiscal fourth quarter, which ended in September, noting that supply chain woes ripped $6 billion from sales amid the tech giant's first earnings miss in five years.</p>\n<p>Group revenues, Apple said, rose 29% from last year to $83.4 billion, just shy of analysts' estimates of an $84.8 billion tally.</p>\n<p>Apple's holiday quarter sales will also be hit by the chip shortage, Cook said, telling Reuters that \"we're doing everything we can do to get more (chips) and also everything we can do operationally to make sure we're moving just as fast as possible.\"</p>\n<p>Still, CFO Luca Maestri told investors on a conference call that December quarter sales would be \"very solid\", and likely hit a record high, with gross margins in the region of 41.5% to 42.5%.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock Surges On Report Saying Autonomous Car Coming in 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock Surges On Report Saying Autonomous Car Coming in 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-19 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/markets/apple-stock-surges-on-report-saying-autonomous-car-coming-in-2025><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple is accelerating its electric car project under Kevin Lynch Bloomberg News reported Thursday, with plans to unveil an autonomous vehicle as early as 2025.\nApple shares surged to a fresh record ...</p>\n\n<a href=\"https://www.thestreet.com/markets/apple-stock-surges-on-report-saying-autonomous-car-coming-in-2025\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/markets/apple-stock-surges-on-report-saying-autonomous-car-coming-in-2025","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104598780","content_text":"Apple is accelerating its electric car project under Kevin Lynch Bloomberg News reported Thursday, with plans to unveil an autonomous vehicle as early as 2025.\nApple shares surged to a fresh record high Thursday amid reports that the world's biggest tech company is accelerating its plans to build a self-driving car, and could unveil its debut model as early as 2025.\nBloomberg News reported that the tech giant is aiming for a fully autonomous vehicle, with new division head Kevin Lynch looking for a faster-than-forecast release.\nThe report follows speculation that Apple, which has long been connected to an autonomous driving project, had visited automakers and suppliers in Asia, including $Toyota Motor Co. (TM)$, as part of its early-stage preparations.\nCitigroup analyst Jim Suva argued in March that an electric car rollout could propel Apple to a $3 trillion market cap, while Wedbush analysts Dan Ives, a long-time Apple bull, told TheStreet in August that a so-called Apple Car is \"not a matter of if, it’s a matter of when.\"\n\"I believe they are continuing to build a vision, the infrastructure, they are looking for partnerships on the battery side,\" he said \"They are not going to miss out on the $5 trillion green tidal wave.”\nApple shares ended 2.85% higher on the session at $157.87 each, an all-time closing high that extends their year-to-date gain to around 22%.\n\nLynch, Apple's vice president of technology, was tabbed to lead Project Titan, the group's autonomous car project, in early summer. That was in addition to the hiring of BWM's Ulrich Kranz, a 30-year industry veteran who lead the German automaker's development of the i3 and i8 electric and hybrid cars.\nApple posted profits of $1.24 per share for its fiscal fourth quarter, which ended in September, noting that supply chain woes ripped $6 billion from sales amid the tech giant's first earnings miss in five years.\nGroup revenues, Apple said, rose 29% from last year to $83.4 billion, just shy of analysts' estimates of an $84.8 billion tally.\nApple's holiday quarter sales will also be hit by the chip shortage, Cook said, telling Reuters that \"we're doing everything we can do to get more (chips) and also everything we can do operationally to make sure we're moving just as fast as possible.\"\nStill, CFO Luca Maestri told investors on a conference call that December quarter sales would be \"very solid\", and likely hit a record high, with gross margins in the region of 41.5% to 42.5%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1466,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876639332,"gmtCreate":1637300696966,"gmtModify":1637300697083,"author":{"id":"4087993342728370","authorId":"4087993342728370","name":"kenlim45","avatar":"https://static.tigerbbs.com/041f7cb113fb34ffb16e6418486502fe","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087993342728370","authorIdStr":"4087993342728370"},"themes":[],"htmlText":"Great 👍&nbsp;","listText":"Great 👍&nbsp;","text":"Great 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876639332","repostId":"1176213248","repostType":2,"repost":{"id":"1176213248","kind":"news","pubTimestamp":1637298830,"share":"https://www.laohunote.com/m/news/1176213248?lang=&edition=full","pubTime":"2021-11-19 13:13","market":"us","language":"en","title":"Electric Vehicle Checkpoint: EV Market May Quadruple By 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=1176213248","media":"The Street","summary":"The current EV market is expected to rise to $957.42 billion from $208.95 billion, a number that cou","content":"<p>The current EV market is expected to rise to $957.42 billion from $208.95 billion,&nbsp;a number that could more than quadruple by 2030, according to a Market Research Future report.</p>\n<p>Along with rising demand, fuel prices and various government initiatives willpush more people toward electric cars. The research firm estimates a CAGR of 24.51% during the period between 2022 and 2030.</p>\n<p>\"Tax breaks, non-monetary benefits such as new car registration and carpool lane access, increased vehicle range, active participation of OEMs, provision of charging infrastructure in regular places, and other factors can all contribute to the expansion of EV market trends,\" reads the report.</p>\n<p>IHS Markit data dug upby CNBCfound that, while Teslas accounted for 79% of all electric vehicles sold in 2020, things will not remain that way for long as hundreds of new models hit the market by 2025. In 2021, there were only several dozen available.</p>\n<p>Shares of electric auto heavyweights $Tesla&nbsp;(<b>TSLA</b>)$, $Lucid&nbsp;(<b>LCID</b>)$ and $Fisker&nbsp;(<b>FSR</b>)$ declined Thursday. The stocks receiving target-price increases from Bank of America Wednesday.</p>\n<p>Tesla has soared 36% over the past month, despite its drop in the past few days. The Nasdaq Composite for Tesla has gained 9% in the last month. Lucid has skyrocketed 85% over the past month and Fisker has leaped 46% in the last month.</p>\n<p>Bank of America analysts, led by John Murphy,raised their targetfor Tesla to $1,200 from $1,000, for Lucid to $60 from $30, and for Fisker to $24 from $18. Murphy has a buy rating on Lucid and a neutral rating on Fisker and Tesla.</p>\n<p>“It is debatable whether any of the start-up EV automakers will ultimately be dominant over the long run, especially in a very competitive industry where the traditional automakers are also ramping up EV efforts,” Murphy wrote in a commentary. “However, if a large global footprint can be built with no-cost capital, the growth story will likely continue to carry the day for the stocks.\"</p>\n<p>Lucid&nbsp;shares continued their ascent on Wednesday, rising another 7% in premarket trading, pushing the luxury electric vehicle maker’s market value at near $90 billion – more than $Ford&nbsp;(<b>F</b>)$, and right behind $General Motors&nbsp;(<b>GM</b>)$. The stock came back to Earth Thursday, down more than 16% in midday trade.</p>\n<p>Lucid’s gains come less than four months since going public through a special purpose acquisition company, or SPAC deal, with Churchill Capital IV.Since that time, Lucid’s stock price has gained more than 80%.</p>\n<p>It also comes as investorspile into all things EV-related– both car and truck companies and related entities that do everything from creating the chips and other parts that go into electric vehicles,to the network of chargers that will keep cars and trucks without engines moving.</p>\n<p>Lucid’s market cap is still well below that of electric vehicle lynchpin Tesla, whose market cap has surged past $1 trillion this year. Rivian&nbsp;(<b>RIVN</b>) -Get RIVIAN AUTOMOTIVE, INC. Report,another EV start-up that went public last week, has a market capof about $140 billion.</p>\n<p>Rivian Automotive, the newest and biggest entrant in the EV space, looked set to clear $125 a share after going public at $78 a share. But shares pulled back Thursday, also down more than 16% at $121.47.</p>\n<p>Tesla rival and Chinese automaker Geely&nbsp;(<b>GELYF</b>)&nbsp;reportedly plans to launch its new heavy-duty electric truck, designed for the global market, by 2024, the Shanghai company told CNBC.&nbsp;Geely’s commercial vehicle group, Farizon Auto, is planning to roll out the new Homtruck in 2024 with an eye on international markets. The big rig Homtruck will have different power options including methanol hybrid and pure electric, CNBC reported.</p>\n<p>Amid growing enthusiasm for all things that move on four wheels and don’t require gasoline, there's also optimism for companies like EVGo&nbsp;(<b>EVGO</b>) and Blink Charging&nbsp;(<b>BLNK</b>) , which&nbsp;arebuilding out the charging infrastructureneeded to keep EVs charged and on the roads.</p>\n<p>Apple&nbsp;(<b>AAPL</b>)&nbsp;is even accelerating its plans to build a self-driving car, which could unveil its debut model as early as 2025.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Electric Vehicle Checkpoint: EV Market May Quadruple By 2030</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElectric Vehicle Checkpoint: EV Market May Quadruple By 2030\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-19 13:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/technology/electric-vehicle-checkpoint-ev-market-may-quadruple-by-2030><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The current EV market is expected to rise to $957.42 billion from $208.95 billion, a number that could more than quadruple by 2030, according to a Market Research Future report.\nAlong with rising ...</p>\n\n<a href=\"https://www.thestreet.com/technology/electric-vehicle-checkpoint-ev-market-may-quadruple-by-2030\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIVN":"Rivian Automotive, Inc.","TSLA":"特斯拉","LUCD":"LUCID DIAGNOSTICS INC.","FSR":"菲斯克","GM":"通用汽车","AAPL":"苹果","F":"福特汽车"},"source_url":"https://www.thestreet.com/technology/electric-vehicle-checkpoint-ev-market-may-quadruple-by-2030","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176213248","content_text":"The current EV market is expected to rise to $957.42 billion from $208.95 billion, a number that could more than quadruple by 2030, according to a Market Research Future report.\nAlong with rising demand, fuel prices and various government initiatives willpush more people toward electric cars. The research firm estimates a CAGR of 24.51% during the period between 2022 and 2030.\n\"Tax breaks, non-monetary benefits such as new car registration and carpool lane access, increased vehicle range, active participation of OEMs, provision of charging infrastructure in regular places, and other factors can all contribute to the expansion of EV market trends,\" reads the report.\nIHS Markit data dug upby CNBCfound that, while Teslas accounted for 79% of all electric vehicles sold in 2020, things will not remain that way for long as hundreds of new models hit the market by 2025. In 2021, there were only several dozen available.\nShares of electric auto heavyweights $Tesla (TSLA)$, $Lucid (LCID)$ and $Fisker (FSR)$ declined Thursday. The stocks receiving target-price increases from Bank of America Wednesday.\nTesla has soared 36% over the past month, despite its drop in the past few days. The Nasdaq Composite for Tesla has gained 9% in the last month. Lucid has skyrocketed 85% over the past month and Fisker has leaped 46% in the last month.\nBank of America analysts, led by John Murphy,raised their targetfor Tesla to $1,200 from $1,000, for Lucid to $60 from $30, and for Fisker to $24 from $18. Murphy has a buy rating on Lucid and a neutral rating on Fisker and Tesla.\n“It is debatable whether any of the start-up EV automakers will ultimately be dominant over the long run, especially in a very competitive industry where the traditional automakers are also ramping up EV efforts,” Murphy wrote in a commentary. “However, if a large global footprint can be built with no-cost capital, the growth story will likely continue to carry the day for the stocks.\"\nLucid shares continued their ascent on Wednesday, rising another 7% in premarket trading, pushing the luxury electric vehicle maker’s market value at near $90 billion – more than $Ford (F)$, and right behind $General Motors (GM)$. The stock came back to Earth Thursday, down more than 16% in midday trade.\nLucid’s gains come less than four months since going public through a special purpose acquisition company, or SPAC deal, with Churchill Capital IV.Since that time, Lucid’s stock price has gained more than 80%.\nIt also comes as investorspile into all things EV-related– both car and truck companies and related entities that do everything from creating the chips and other parts that go into electric vehicles,to the network of chargers that will keep cars and trucks without engines moving.\nLucid’s market cap is still well below that of electric vehicle lynchpin Tesla, whose market cap has surged past $1 trillion this year. Rivian (RIVN) -Get RIVIAN AUTOMOTIVE, INC. Report,another EV start-up that went public last week, has a market capof about $140 billion.\nRivian Automotive, the newest and biggest entrant in the EV space, looked set to clear $125 a share after going public at $78 a share. But shares pulled back Thursday, also down more than 16% at $121.47.\nTesla rival and Chinese automaker Geely (GELYF) reportedly plans to launch its new heavy-duty electric truck, designed for the global market, by 2024, the Shanghai company told CNBC. Geely’s commercial vehicle group, Farizon Auto, is planning to roll out the new Homtruck in 2024 with an eye on international markets. The big rig Homtruck will have different power options including methanol hybrid and pure electric, CNBC reported.\nAmid growing enthusiasm for all things that move on four wheels and don’t require gasoline, there's also optimism for companies like EVGo (EVGO) and Blink Charging (BLNK) , which arebuilding out the charging infrastructureneeded to keep EVs charged and on the roads.\nApple (AAPL) is even accelerating its plans to build a self-driving car, which could unveil its debut model as early as 2025.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1519,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"followers","isTTM":false}